View of Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice

Return to Article Details Pharmacoeconomic analysis of switch to faricimab for neovascular age-related macular degeneration in real clinical practice Download Download PDF